TetraScience Welcomes Matt Studney as Chief Customer Officer
In a significant move that underscores a transformative shift within the biopharma industry, TetraScience has announced the appointment of Matt Studney as its new Chief Customer Officer. This appointment comes at a time when the emphasis on platform-based solutions in scientific artificial intelligence (AI) is becoming increasingly paramount.
Matt Studney, a veteran with 24 years of experience at Merck, where he served as Senior Vice President of Research and Development IT, played a vital role in modernizing numerous scientific platforms. During his tenure at Merck, Studney led efforts that enhanced operational efficiencies, accelerated scientific decision-making, and improved data management across the organization. His leadership was instrumental in integrating cloud technologies, AI capabilities, and empowering over 18,000 scientists and researchers to work more collaboratively and effectively.
Studney’s decision to join TetraScience is not solely indicative of his personal career trajectory but reflects a broader pivot within the bio-pharmaceutical landscape. As scientific data complexity escalates and the role of AI becomes more central to competitive advantage, organizations are increasingly favoring platform-based methodologies over bespoke, project-driven approaches.
Patrick Grady, co-founder and CEO of TetraScience, expressed that Studney’s firsthand experience with the limitations of traditional, artisanal methods in scientific data management makes him a perfect fit for the company's vision. He noted, "Matt has witnessed firsthand the constraints of tailored approaches to scientific data and AI. His transition signifies a shift from standalone internal efforts to shared platforms that are meticulously designed to provide scientific intelligence that’s sustainable, cumulative, and scalable."
Throughout his career, Matt Studney successfully established strategic partnerships with renowned technology and consulting firms like AWS, Accenture, Veeva, and NVIDIA. His contributions during his tenure at Merck not only helped modernize clinical and laboratory technologies but also significantly cut discovery cycle times by 33% and expedited regulatory submissions, achieving remarkable savings of upwards of $100 million within the first six months of an extensive optimization program.
Reflecting on his professional journey, Studney stated, “In the course of my career at one of the world’s most complex pharma organizations, I’ve gained insights into what strategies effectively propagate scientific intelligence across the global pharma landscape. The AI era necessitates a fundamentally new architectural basis to drive true transformation. Fragmented data and tailored workflows cannot support scalable scientific intelligence; TetraScience’s platform is constructed specifically for industrializing scientific data and enabling cumulative learning at an enterprise level.”
At TetraScience, Studney’s role will involve collaborating closely with biopharma customers, guiding them from project-based modernization to the establishment of a unified scientific data and AI platform. This transition will also demand organizational and operational shifts, aligning efforts with TetraScience’s Sciborg model aimed at translating platform architecture into sustainable adoption and measurable scientific outcomes across discovery, development, and production stages.
About TetraScience
TetraScience is a pioneering company focused on scientific data and AI, developing Tetra OS, a robust operating system for scientific intelligence. This platform integrates various capabilities, such as the Scientific Data Foundry, Scientific Use Case Factory, and Tetra AI, into a comprehensive solution designed to redefine fragmented scientific data workflows into regulated, reusable intelligence. Trusted by leading biopharmaceutical organizations and ecosystem partners including NVIDIA, Databricks, and Google, TetraScience continues to be at the forefront of innovation in the scientific space.
For more detailed information, visit
TetraScience's official website.